1 min read •
Pharmaceutical companies have a pragmatic approach
Considered as the big winner against pandemic flu, vaccine manufacturers have to kiss goodbye the sale millions of doses of vaccines in France, a rather limited financial setback.
Considered as the big winner against pandemic flu, vaccine manufacturers have to kiss goodbye the sale millions of doses of vaccines in France, a rather limited financial setback.
RELATED INFORMATION
Pharma: Strategic realignment for a better future
Amid the search for effective COVID-19 treatments and vaccines, the pandemic will have long-term side effects for the global pharmaceutical industry. As our article explains, companies will need to…
Impact of Digital Health on the Pharmaceutical Industry
This is the result of a global survey conducted in the Pharmaceutical industry by Arthur D. Little and the Karlsruher Institute of Technology (KIT) to capture the current thinking and the…
Identifying Strategic Environmental Opportunities: A Life Cycle Approach
Leading companies now recognize that commitment to the environment can help them not only avoid costly problems or liabilities, but also identify environmentally based opportunities for competitive…